4D Molecular Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 5.65 M | $42.40 M | 23.89% | 10.07% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.64 M | $34.73 M | 164.40% | 8.26% |
| BVF INC/IL | 02/17/2026 | 4.63 M | $34.72 M | 0.00% | 8.25% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 4.30 M | $32.27 M | 4.23% | 7.67% |
| BLACKROCK, INC. | 02/12/2026 | 4.06 M | $30.49 M | 5.06% | 7.24% |
| NOVO HOLDINGS A/S | 02/17/2026 | 3.65 M | $27.38 M | 82.54% | 6.50% |
| VANGUARD GROUP INC | 01/29/2026 | 3.09 M | $23.20 M | 20.13% | 5.51% |
| STATE STREET CORP | 02/13/2026 | 2.69 M | $20.17 M | 197.52% | 4.79% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 1.94 M | $14.52 M | 76.64% | 3.45% |
| FEDERATED HERMES, INC. | 02/12/2026 | 1.61 M | $12.07 M | 0.92% | 2.87% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.54 M | $11.55 M | 100.00% | 2.74% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 1.24 M | $9.26 M | 605.80% | 2.20% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.01 M | $7.59 M | 10.78% | 1.80% |
| EVERGREEN QUALITY FUND GP, LTD. | 02/17/2026 | 951.47 K | $7.14 M | 100.00% | 1.70% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 832.59 K | $6.24 M | 1.63% | 1.48% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 704.21 K | $5.28 M | 29.61% | 1.25% |
| MORGAN STANLEY | 02/13/2026 | 672.70 K | $5.05 M | -19.53% | 1.20% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 512.90 K | $3.85 M | 63.77% | 0.91% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 503.43 K | $3.78 M | 151.72% | 0.90% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 485.39 K | $3.64 M | -3.71% | 0.86% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 477.51 K | $3.58 M | 1.32% | 0.85% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 475.74 K | $3.57 M | 100.00% | 0.85% |
| RTW INVESTMENTS, LP | 02/17/2026 | 475.74 K | $3.57 M | 100.00% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 353.39 K | $2.65 M | 15.54% | 0.63% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 337.50 K | $2.53 M | 23.40% | 0.60% |
| NORTHERN TRUST CORP | 02/17/2026 | 313.82 K | $2.35 M | -6.49% | 0.56% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 296.20 K | $2.22 M | -55.37% | 0.53% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 294.84 K | $2.21 M | 408.29% | 0.53% |
| JPMORGAN CHASE & CO | 02/11/2026 | 279.51 K | $2.10 M | -45.57% | 0.50% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 275.30 K | $2.06 M | -49.92% | 0.49% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 275.00 K | $2.06 M | 100.00% | 0.49% |
| PEAPOD LANE CAPITAL LLC | 01/28/2026 | 268.02 K | $2.01 M | -16.78% | 0.48% |
| UBS GROUP AG | 01/29/2026 | 231.29 K | $1.73 M | 143.72% | 0.41% |
| JANE STREET GROUP, LLC | 02/12/2026 | 224.90 K | $1.69 M | 92.36% | 0.40% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 210.00 K | $1.58 M | 6.35% | 0.37% |
| WOODLINE PARTNERS LP | 02/17/2026 | 200.00 K | $1.50 M | 100.00% | 0.36% |
| BARCLAYS PLC | 02/13/2026 | 170.64 K | $1.28 M | 81.86% | 0.30% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 161.98 K | $1.21 M | -9.55% | 0.29% |
| NUVEEN, LLC | 02/12/2026 | 158.77 K | $1.19 M | 69.05% | 0.28% |
| INVESCO LTD. | 02/19/2026 | 153.14 K | $1.15 M | 20.99% | 0.27% |
| PERIGON WEALTH MANAGEMENT, LLC | 01/16/2026 | 146.13 K | $1.10 M | 0.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 136.74 K | $1.03 M | -3.51% | 0.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 130.25 K | $976.89 K | -3.85% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 126.01 K | $945.10 K | -5.12% | 0.22% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 116.71 K | $875.34 K | 598.37% | 0.21% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 111.82 K | $838.67 K | 1,007.15% | 0.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 100.00 K | $750.00 K | 100.00% | 0.18% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 96.36 K | $722.73 K | -91.62% | 0.17% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 91.08 K | $683.13 K | 30.83% | 0.16% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 83.41 K | $625.60 K | 100.00% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 184 institutional investors and hedge funds held shares of 4D Molecular Therapeutics Inc. The most heavily invested institutionals were:
FEDERATED HERMES, INC.: 1.43 M
DEUTSCHE BANK AG\: 708,044
Nuveen, LLC: 561,805
DIMENSIONAL FUND ADVISORS LP: 522,823
Invesco Ltd.: 310,684
Peapod Lane Capital LLC: 241,480
95.19% of 4D Molecular Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 58.71 M shares in the last 24 months. This purchase volume represents approximately $512.57 M in transactions.